Richtlijn Guillain-Barré syndroom

Fysieke restverschijnselenDe Jager AEJ, Minderhoud JM. Residual signs in severe Guillain-Barré syndrome: analysis of57 patients. Neurol Sci 1991;104:151-6.Dornonville de la Cour C, Jakobsen J. Residual neuropathy in long-term population-basedfollow-up of Guillain–Barré syndrome. Neurology 2005;64;246-253.Forsberg A, Press R, Einarsson U, De-Pedro CJ, Widen HL. Impairment in Guillain-Barrésyndrome during the first 2 years after onset: A prospective study. J Neurol Sci 2004;227(1):131-138.Koeppen S, Kraywinkel K, Wessendorf TE, Ehrenfeld CE, Schurks M, Diener HC, et al. Longtermoutcome of Guillain-Barré syndrome. Neurocrit.Care 2006; 5(3):235-242.Korinthenberg R, Schessl J, Kirschner J. Clinical Presentation and Course of childhood Guillain-Barré syndrome: A Prospective Multicentre Study. Neuropediatrics 2007;38:10–17.Vajsar J, Fehlings D, Stephens D. Long-term outcome in children with Guillain-Barré Syndrome.J Pediatr 2003;142:305-9.Vedeler CA, Wik E, Nyland H. The long-term prognosis of Guillain-Barré syndrome. Evaluationof prognostic factors including plasma exchange. Acta Neurol Scand 1997;95:298–302.148